Executive Summary

In Europe and the US there are close to 20 million people that live with cancer today, a figure that is increasing. 6.2 million people worldwide died of cancer in 1998. The American Cancer Society estimates that approximately 1.2 million new cancer cases were diagnosed in the year 2000 in the US. Overall annual costs associated with cancer currently amount to $107 billion in the United States alone. The worldwide anti-cancer market was valued at more than $15 billion in 1998 and is projected to nearly double by 2003. Approximately 30% of all collaborative deals are signed in the field of cancer. 

There are several types of breast cancer. The most common is ductal carcinoma, which begins in the lining of the milk ducts of the breast. Another type, lobular carcinoma, begins in the lobules where breast milk is produced. If a malignant tumor invades nearby tissue, it is known as infiltrating or invasive cancer. Therapeutic decisions are formulated in part according to staging categories but primarily according to tumor size, lymph node status, estrogen- and progesterone-receptor levels in the tumor tissue, menopausal status, and the general health of the patient. 

One in 8 women in the United States (approximately 13.3 percent) will develop breast cancer during her lifetime (NCI). According to CDC, the incidence of invasive breast cancer has shown a small increase during the last 30 years, probably due to an increasingly aged population. Even with an increasing incidence, the mortality rate has dropped slightly during the last 10-15 years. The most dramatic decrease is seen in younger patients (<50 years). 

The Global Structure of Breast Cancer R&D is one of the most comprehensive and up to date information sources currently available in the breast cancer R&D arena. Information about new innovative cancer therapies such as antisense, monoclonal antibodies, gene therapy, antigen- or cellular-based vaccines, liposomal hormones and apoptotic drugs are analyzed in more than 100 extensive tables and graphs. This report will give yo u easy-to-read tables with projects classified into well-defined structures based on type of therapy given, effect and mechanism. The graphs provide all the relations of these factors as well as the general and specific trends in the current breast cancer pipeline.

Size: 302 pages

Release date: Sep 26, 2003

Publisher: BioSeeker 2003

To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/BioSeeker_2003.html#a467